- Home
- LFMDP vs XELLL Comparison
LFMDP vs XELLL Comparison
Compare LFMDP & XELLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$21.30
Company Overview
Basic Information| Metric | LFMDP | XELLL |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 384 | N/A |
| Industry | Medical/Nursing Services | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2012 | 2003 |
Fundamental Metrics
Financial Performance| Metric | LFMDP | XELLL |
|---|---|---|
| Price | $21.30 | $21.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.8K | ★ 153.2K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 141.67 | N/A |
| EPS | N/A | ★ 1.82 |
| Revenue | $12,468,578.00 | ★ $11,537,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.66 |
| Revenue Growth | ★ 49.79 | N/A |
| 52 Week Low | $18.50 | $20.53 |
| 52 Week High | $24.20 | $25.59 |
Technical Indicators
Market Signals| Indicator | LFMDP | XELLL |
|---|---|---|
| Relative Strength Index (RSI) | 32.80 | 49.11 |
| Support Level | $20.97 | $21.16 |
| Resistance Level | $23.70 | $21.61 |
| Average True Range (ATR) | 0.44 | 0.47 |
| MACD | -0.12 | 0.07 |
| Stochastic Oscillator | 15.29 | 69.44 |
Price Performance
Historical Comparison LFMDP
XELLL
About LFMDP LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.